In our nomogram, we combined seven variables (PLT, CEA, AFP, tumor location, tumor differentiation, lymph node metastasis, and chemotherapy) recognized from multivariate analysis with the TNM stage to optimize clinical practice. The gene discussed is CEACAM5; the disease is neoplasm.